metronidazole has been researched along with avibactam in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Citron, DM; Goldstein, EJ; Merriam, V; Tyrrell, KL | 1 |
| Dubreuil, LJ; Mahieux, S; Miossec, C; Neut, C; Pace, J | 1 |
| Lipka, J; Lucasti, C; Popescu, I; Ramesh, MK; Sable, C | 1 |
| Buising, KL; Cronin, K; Jeremiah, CJ; Mandrawa, CL; Poy Lorenzo, YS; Waters, MJ | 1 |
| Fu, J; Li, X; Lv, Q; Shi, X; Wan, X; Xu, Q | 1 |
1 trial(s) available for metronidazole and avibactam
| Article | Year |
|---|---|
Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Intraabdominal Infections; Male; Meropenem; Metronidazole; Middle Aged; Placebos; Thienamycins; Treatment Outcome; Young Adult | 2013 |
4 other study(ies) available for metronidazole and avibactam
| Article | Year |
|---|---|
In vitro activity of ceftazidime-NXL104 against 396 strains of beta-lactamase-producing anaerobes.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria, Anaerobic; Ceftazidime; Enterobacteriaceae; Metronidazole; Microbial Sensitivity Tests | 2011 |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria, Anaerobic; beta-Lactamase Inhibitors; Drug Resistance, Bacterial; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests | 2012 |
Carbapenemase-producing Klebsiella pneumoniae: a major clinical challenge.
Topics: Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Middle Aged; Pancreatic Diseases; Teicoplanin | 2016 |
Cost-effectiveness of ceftazidime/avibactam plus metronidazole versus meropenem as first-line empiric therapy for the treatment of complicated intra-abdominal infections: A study based on the in-vitro surveillance data in China.
Topics: Anti-Bacterial Agents; Ceftazidime; Cost-Benefit Analysis; Humans; Intraabdominal Infections; Meropenem; Metronidazole; Microbial Sensitivity Tests | 2023 |